Skip to main content

Kenison Michael R.'s Form 4 filing

Proto Labs Inc (PRLB) · filed May 13, 2026

Accession no.
0001628280-26-034651
Filed
May 13, 2026
Trade date
May 11-12, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 10 non-derivative transactions and 5 derivative transactions. Open-market sales total $1.64M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kenison Michael R.CIK 0001870293Officer (Chief Operations Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 11, 2026Common StockMOption exerciseAcquired+3,756$33.84+$127,103.0430,942Direct
May 11, 2026Common StockMOption exerciseAcquired+3,677$33.52+$123,253.0434,619Direct
May 11, 2026Common StockSSaleDisposed−7,433$70.26F2−$522,242.5827,186Direct
May 12, 2026Common StockMOption exerciseAcquired+1,928$33.84+$65,243.5229,114Direct
May 12, 2026Common StockMOption exerciseAcquired+1,557$39.61+$61,672.7730,671Direct
May 12, 2026Common StockMOption exerciseAcquired+4,042$59.40+$240,094.834,713Direct
May 12, 2026Common StockSSaleDisposed−1,613$67.58F3−$109,006.5433,100Direct
May 12, 2026Common StockSSaleDisposed−4,198$68.70F4−$288,402.628,902Direct
May 12, 2026Common StockSSaleDisposed−3,576$69.78F5−$249,533.2825,326Direct
May 12, 2026Common StockSSaleDisposed−6,643$70.30F6−$467,002.918,683Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 11, 2026Common StockMOption exerciseDisposed−3,756$0.00$03,856Direct
May 11, 2026Common StockMOption exerciseDisposed−3,677$0.00$03,778Direct
May 12, 2026Common StockMOption exerciseDisposed−1,928$0.00$01,928Direct
May 12, 2026Common StockMOption exerciseDisposed−1,557$0.00$04,674Direct
May 12, 2026Common StockMOption exerciseDisposed−4,042$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Reflects the weighted average price of 7,433 shares of common stock of Proto Labs Inc. sold by the reporting person in multiple transactions on May 11, 2026, with sale prices ranging from $70.00 to $70.57 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

Reflects the weighted average price of 1,613 shares of common stock of Proto Labs Inc. sold by the reporting person in multiple transactions on May 12, 2026, with sale prices ranging from $67.06 to $68.05 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

Reflects the weighted average price of 4,198 shares of common stock of Proto Labs Inc. sold by the reporting person in multiple transactions on May 12, 2026, with sale prices ranging from $68.10 to $69.0425 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F5

Reflects the weighted average price of 3,576 shares of common stock of Proto Labs Inc. sold by the reporting person in multiple transactions on May 12, 2026, with sale prices ranging from $69.13 to $70.1181 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F6

Reflects the weighted average price of 6,643 shares of common stock of Proto Labs Inc. sold by the reporting person in multiple transactions on May 12, 2026, with sale prices ranging from $70.13 to $70.57 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)